SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Genesco Inc. (GCO) trades at a trailing P/E of 24.1, forward P/E of 15.4. Trailing earnings yield is 4.14%, forward earnings yield 6.49%. PEG 0.22 (Peter Lynch undervalued ≤1.0). Graham Number is $39.80.
Criteria proven by this page:
- VALUE (82/100, Pass) — P/E is below market average (24.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.22); analyst target implies upside (+14.6%); earnings yield beats bond yields (4.14%).
- Forward P/E 15.4 (down from trailing 24.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.14% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 6.49% as earnings recover.
- Analyst consensus target $37.75 (+14.6% upside) — modest upside expected.
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
82/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GCO
Valuation Multiples
P/E (TTM)24.1
Forward P/E15.4
PEG Ratio0.22
Forward PEG0.22
P/B Ratio0.56
P/S Ratio0.14
EV/EBITDA37.3
Per Share Data
EPS (TTM)$1.28
Forward EPS (Est.)$2.14
Book Value / Share$54.85
Revenue / Share$235.62
FCF / Share$14.10
Yields & Fair Value
Earnings Yield4.14%
Forward Earnings Yield6.49%
Dividend Yield0.00%
Graham Number$39.80
SharesGrow IV$1,444.69 (+4287.2%)
Analyst Target$37.75 (+14.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
12.4 |
0.82 |
1.31 |
0.42 |
- |
| 2018 |
-6.0 |
0.03 |
0.81 |
0.23 |
- |
| 2019 |
-16.8 |
0.31 |
1.19 |
0.40 |
- |
| 2020 |
10.0 |
-0.04 |
0.99 |
0.28 |
- |
| 2021 |
-10.1 |
0.05 |
1.00 |
0.32 |
- |
| 2022 |
7.9 |
-0.03 |
1.51 |
0.38 |
- |
| 2023 |
8.4 |
-0.29 |
0.99 |
0.25 |
- |
| 2024 |
-18.6 |
0.15 |
0.55 |
0.13 |
- |
| 2025 |
-23.9 |
-1.49 |
0.83 |
0.19 |
- |
| 2026 |
22.6 |
-0.13 |
0.53 |
0.12 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$-3.94 |
$1.79B |
$-56.03M |
-3.1% |
| 2022 |
$7.92 |
$2.42B |
$114.85M |
4.7% |
| 2022 |
$7.92 |
$2.42B |
$114.85M |
4.7% |
| 2023 |
$5.66 |
$2.38B |
$71.92M |
3% |
| 2023 |
$5.66 |
$2.38B |
$71.92M |
3% |
| 2024 |
$-1.50 |
$2.32B |
$-16.83M |
-0.7% |
| 2024 |
$-1.50 |
$2.32B |
$-16.83M |
-0.7% |
| 2025 |
$-1.80 |
$2.33B |
$-18.89M |
-0.8% |
| 2025 |
$-1.80 |
$2.33B |
$-18.89M |
-0.8% |
| 2026 |
$1.25 |
$2.44B |
$13.28M |
0.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.33 |
$1.28 – $1.38 |
$2.43B |
$2.42B – $2.43B |
2 |
| 2027 |
$2.14 |
$2.12 – $2.14 |
$2.43B |
$2.42B – $2.44B |
3 |
| 2028 |
$2.74 |
$2.66 – $2.81 |
$2.48B |
$2.47B – $2.49B |
3 |
| 2029 |
$3.25 |
$3.23 – $3.26 |
$2.58B |
$2.57B – $2.58B |
1 |
